News

For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added biological coatings.

Researchers uncover a unique gut immune pathway that produces long-lasting IgA antibodies, offering new strategies for durable mucosal vaccines.

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the production of antibodies.

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.

Scientists have engineered a groundbreaking living medicine, a beneficial probiotic designed to deliver Levodopa or L-DOPA steadily from the gut to the brain of Parkinson’s patients.

Researchers have developed a new way to deliver drugs to the central nervous system, offering hope for multiple sclerosis.

Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system.

A high-precision sequencing study reveals how Epstein–Barr virus transforms B cells into inflammatory drivers that spark the widespread immune attacks seen in lupus.

Researchers at Chiba University have developed a new nasal therapeutic vaccine as a non-invasive treatment option. In animal studies, the vaccine produced strong and lasting immune responses against cervical tumors.

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age of the patient.